Financials
Financial year 2025
BORNEM PHARMA from Bornem, company number BE0465495476, closed financial year 2025 with a result of € 247,989 after tax. For that financial year BORNEM PHARMA recorded a gross margin of € 454,261 and equity of € 303,310. Compared with financial year 2024, the result moved from € 243,113 to € 247,989. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 6, 2026.
€ 303,310
▲ 19% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 247,989
▲ 2% vs 2024
Profit after tax over the fiscal year.
€ 434,852
▲ 30% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 200,000 paid out
81 % of the profit went to the shareholders, mostly to Kevin BULKMANS (100 % of the shares). That is where the money ends up.
People and assets in 2025
2.4
▲ 0.9 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 165,032
▲ 64% vs 2024
€ 68,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,936
▲ € 1,912 vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 349,357
▼ 7% vs 2024
€ 25,330 is repaid this year. At this pace the long-term loan is gone in ≈ 14 years.
€ 105,270
▼ 13% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 36,630
▲ 169% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 309,718 | € 330,431 | € 379,126 | € 454,261 | ▲ 20% |
| Profit after taxes | € 169,286 | € 178,648 | € 243,113 | € 247,989 | ▲ 2% |
| Equity | € 217,560 | € 228,208 | € 255,321 | € 303,310 | ▲ 19% |
| Total debts | € 829,342 | € 842,119 | € 924,732 | € 966,810 | ▲ 5% |
| Cash | € 285,813 | € 294,157 | € 334,018 | € 434,852 | ▲ 30% |
| Land & buildings | € 419,067 | € 408,833 | € 398,600 | € 388,367 | ▼ 3% |
| Retained profit | € 198,960 | € 209,608 | € 236,721 | € 284,710 | ▲ 20% |
| Dividend | € 160,000 | € 168,000 | € 216,000 | € 200,000 | ▼ 7% |
| Bank debt | € 489,096 | € 399,005 | € 374,348 | € 349,357 | ▼ 7% |
| Balance sheet total | € 1,046,902 | € 1,070,327 | € 1,180,052 | € 1,270,120 | ▲ 8% |
| Employees (FTE) | 2 | 1.6 | 1.5 | 2.4 | ▲ 0.9 |
Key figures of BORNEM PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BORNEM PHARMA?
What happened at BORNEM PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 247,989 (▲ 2% vs 2024). filed late Source: NBB ↗
- Kevin Bulkmans BV became a director. NBB
- New establishment in Bornem. KBO
- Start of the company according to the CBE. KBO
In short
From € 169,286 profit in 2022 to € 247,989 profit in 2025.
Paid € 38,173 in corporate taxes since 2022.
Best year ever: 2025, with € 247,989 profit.
On average € 189,300 of value added per employee in 2025.
Management
The stake of Kevin BULKMANS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
BORNEM PHARMABehind BORNEM PHARMA is Kevin Bulkmans BV. The shares are held by Kevin BULKMANS (100%).
Directors
According to the 2025 annual accounts
Director · represented by Bulkmans Kevin
since 2019
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Boomstraat(BOR) 7 box gvl
2880 Bornem
Boomstraat(BOR) 7
2880 Bornem
Active since 20 May 1999
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
UPCLOUD, FI
Website info
Features
Security
Network
Details
- Company number
- 0465.495.476
- VAT number
- BE 0465.495.476
- Registered office
- Boomstraat(BOR) 7 bus gvl, 2880 Bornem
- Names & denominations
- BORNEM PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 March 1999
- Peppol
- Active · Active since 27 Nov 2025
- Contact
- bornempharma.be [email protected]
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers